Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 09:07 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Targeting Leukotrienes in Kidney Disease
NCT05362474 · University of Colorado, Denver · PHASE3 · terminated · last registry update 2025-05-30 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Funding not available” | – | Registry record, University of Colorado, Denver |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CYSLTR1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-04-21Results posted on the registry: Children's Hospital Medical Center, Cincinnati, Montelukast + Placebo (NCT02793375)
- 2026-01-06Phase 3 first posted: Shanghai Zhongshan Hospital, Montelukast + Placebo (NCT07320625)
- 2025-12-15Results posted on the registry: University of California, San Francisco, Montelukast 10 Mg Oral Tablet (NCT04198623)
- 2025-12-11Results posted on the registry: Beth Israel Deaconess Medical Center, Zafirlukast (NCT04339140)
- 2025-11-17Results posted on the registry: Susanna Naggie, MD, Ivermectin + Fluvoxamine (NCT04885530)
- 2025-11-14Results posted on the registry: Sanofi, Isatuximab IV + Isatuximab SC (NCT05405166)
- 2025-10-21Results posted on the registry: Sanofi, AGALSIDASE BETA (GZ419828) + Acetaminophen (NCT06019728)
- 2025-10-20Results posted on the registry: Janssen Research & Development, LLC, Dexamethasone + Montelukast (NCT05663866)
- 2025-09-17Also stopped (terminated): Sanofi, Isatuximab SAR650984 + Acetaminophen (paracetamol) or equivalent (NCT04294459)
- 2025-01-22Results posted on the registry: National Cancer Institute (NCI), Ibrutinib + Steroid pulse (prednisone) (NCT04294641)
- 2024-12-24Phase 3 first posted: Phramongkutklao College of Medicine and Hospital, Montelukast + Montelukast Placebo (NCT06747130)
- 2024-11-26Also stopped (terminated): Chia Tai Tianqing Pharmaceutical Group Co., Ltd., TQC3564 tablets + Placebo tablets (NCT05607446)
- 2024-11-18Also stopped (withdrawn): Vanderbilt University Medical Center, Montelukast Oral Granules (NCT03277170)
- 2024-08-16Results posted on the registry: Susanna Naggie, MD, Montelukast (NCT05894577)
- 2024-07-03Also stopped (terminated): Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina, Montelukast (NCT04695704)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision